XML 47 R11.htm IDEA: XBRL DOCUMENT v3.22.4
Cash and Cash Equivalents and Marketable Securities
12 Months Ended
Dec. 31, 2022
Investments, Debt and Equity Securities [Abstract]  
Cash and Cash Equivalents and Marketable Securities

4. Cash and Cash Equivalents and Marketable Securities

As of December 31, 2022 and 2021, cash and cash equivalents and marketable securities were comprised of the following:

 

 

Amortized Cost

 

 

Unrealized Gains

 

 

Unrealized Losses

 

 

Fair Value

 

 

 

(in thousands)

 

As at December 31, 2022

 

 

 

 

 

 

 

 

 

 

 

 

 Cash and cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

 Cash

 

$

116,526

 

 

$

 

 

$

 

 

$

116,526

 

 Money market funds

 

 

42,995

 

 

 

 

 

 

 

 

 

42,995

 

 Total cash and cash equivalents

 

$

159,521

 

 

$

 

 

$

 

 

$

159,521

 

 Marketable securities:

 

 

 

 

 

 

 

 

 

 

 

 

 U.S. Treasury notes

 

$

58,641

 

 

$

1

 

 

$

(280

)

 

$

58,362

 

 U.S. Treasury bills

 

 

126,207

 

 

 

4

 

 

 

(153

)

 

 

126,058

 

 Total marketable securities

 

$

184,848

 

 

$

5

 

 

$

(433

)

 

$

184,420

 

 

 

 

 

 

 

 

 

 

 

 

 

 

As at December 31, 2021

 

 

 

 

 

 

 

 

 

 

 

 

 Cash and cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

 Cash

 

$

331,892

 

 

$

 

 

$

 

 

$

331,892

 

 Money market funds

 

 

2,535

 

 

 

 

 

 

 

 

 

2,535

 

 Total cash and cash equivalents

 

$

334,427

 

 

$

 

 

$

 

 

$

334,427

 

 Marketable securities:

 

 

 

 

 

 

 

 

 

 

 

 

 U.S. Treasury notes

 

$

7,439

 

 

$

 

 

$

 

 

$

7,439

 

 Total marketable securities

 

$

7,439

 

 

$

 

 

$

 

 

$

7,439

 

Interest receivable was $0.4 million and nil as of December 31, 2022 and 2021, respectively, and is included in other receivables.

The Company held 28 and nil available-for-sale marketable securities with an aggregate fair value of $157.9 million and nil that were in an unrealized loss position as of December 31, 2022 and 2021, respectively. These marketable securities have been in an unrealized loss position for less than twelve months. The unrealized losses as of December 31, 2022 were not attributed to credit risk but were primarily associated with changes in interest rates and market liquidity. The Company does not intend to sell these securities and it is more likely than not that it will hold these investments for a period of time sufficient to recover the amortized cost. As a result, the Company did not record

an allowance for credit losses or other impairment charges for its marketable securities for the year ended December 31, 2022.

The Company recognized $0.4 million and nil in net unrealized losses in other comprehensive loss for the years ended December 31, 2022 and 2021, respectively.

The maturities of the Company’s marketable securities as of December 31, 2022 and 2021 are less than one year.